Literature DB >> 27826634

The optimal blood glucose target in critically ill patients: more questions than answers.

Jan Gunst1, Gordon S Doig2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27826634     DOI： 10.1007/s00134-016-4610-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  14 in total

1.  Intensive insulin therapy in critically ill patients.

Authors:  G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life.

Authors:  Catherine Ingels; Yves Debaveye; Ilse Milants; Erik Buelens; Ann Peeraer; Yves Devriendt; Tom Vanhoutte; Aurelie Van Damme; Miet Schetz; Pieter J Wouters; Greet Van den Berghe
Journal:  Eur Heart J       Date:  2006-04-11       Impact factor: 29.983

3.  Intensive versus conventional glucose control in critically ill patients.

Authors:  Simon Finfer; Dean R Chittock; Steve Yu-Shuo Su; Deborah Blair; Denise Foster; Vinay Dhingra; Rinaldo Bellomo; Deborah Cook; Peter Dodek; William R Henderson; Paul C Hébert; Stephane Heritier; Daren K Heyland; Colin McArthur; Ellen McDonald; Imogen Mitchell; John A Myburgh; Robyn Norton; Julie Potter; Bruce G Robinson; Juan J Ronco
Journal:  N Engl J Med       Date:  2009-03-24       Impact factor: 91.245

Review 4.  Glycemic control, mortality, and hypoglycemia in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials.

Authors:  Tomohide Yamada; Nobuhiro Shojima; Hisashi Noma; Toshimasa Yamauchi; Takashi Kadowaki
Journal:  Intensive Care Med       Date:  2016-09-16       Impact factor: 17.440

Review 5.  Tight glycemic control in acutely ill patients: low evidence of benefit, high evidence of harm!

Authors:  Paul E Marik
Journal:  Intensive Care Med       Date:  2016-05-09       Impact factor: 17.440

6.  Early versus late parenteral nutrition in critically ill adults.

Authors:  Michael P Casaer; Dieter Mesotten; Greet Hermans; Pieter J Wouters; Miet Schetz; Geert Meyfroidt; Sophie Van Cromphaut; Catherine Ingels; Philippe Meersseman; Jan Muller; Dirk Vlasselaers; Yves Debaveye; Lars Desmet; Jasperina Dubois; Aime Van Assche; Simon Vanderheyden; Alexander Wilmer; Greet Van den Berghe
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

7.  Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study.

Authors:  Dirk Vlasselaers; Ilse Milants; Lars Desmet; Pieter J Wouters; Ilse Vanhorebeek; Ingeborg van den Heuvel; Dieter Mesotten; Michael P Casaer; Geert Meyfroidt; Catherine Ingels; Jan Muller; Sophie Van Cromphaut; Miet Schetz; Greet Van den Berghe
Journal:  Lancet       Date:  2009-01-26       Impact factor: 79.321

Review 8.  Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis.

Authors:  Paul E Marik; Jean-Charles Preiser
Journal:  Chest       Date:  2009-12-16       Impact factor: 9.410

Review 9.  The optimal target for acute glycemic control in critically ill patients: a network meta-analysis.

Authors:  Tomoaki Yatabe; Shigeaki Inoue; Masahiko Sakaguchi; Moritoki Egi
Journal:  Intensive Care Med       Date:  2016-09-29       Impact factor: 17.440

10.  Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: a randomized controlled trial.

Authors:  Dieter Mesotten; Marijke Gielen; Caroline Sterken; Kirsten Claessens; Greet Hermans; Dirk Vlasselaers; Jurgen Lemiere; Lieven Lagae; Marc Gewillig; Benedicte Eyskens; Ilse Vanhorebeek; Pieter J Wouters; Greet Van den Berghe
Journal:  JAMA       Date:  2012-10-24       Impact factor: 56.272
View more
  2 in total

1.  Modified Glucose-Insulin-Potassium Regimen Provides Cardioprotection With Improved Tissue Perfusion in Patients Undergoing Cardiopulmonary Bypass Surgery.

Authors:  Kun Zhao; Yue Zhang; Jia Li; Qin Cui; Rong Zhao; Wensheng Chen; Jincheng Liu; Bijun Zhao; Yi Wan; Xin-Liang Ma; Shiqiang Yu; Dinghua Yi; Feng Gao
Journal:  J Am Heart Assoc       Date:  2020-03-10       Impact factor: 5.501

2.  Effect of glycemic gap upon mortality in critically ill patients with diabetes.

Authors:  Ran Lou; Li Jiang; Bo Zhu
Journal:  J Diabetes Investig       Date:  2021-08-03       Impact factor: 4.232
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.